Categories: Wire Stories

MIR M, MMORPG from Wemade, launching globally on January 31

  • 8 directional movement, Mandala system and inter-game economy with MIR4 all possible on MIR M
  • Supporting 12 languages in more than 170 countries and launching both in mobile and PC�
  • Pre-register now and complete missions to receive DOGMA

SEOUL, South Korea–(BUSINESS WIRE)–#DOGMA–Wemade’s new MMORPG MIR M : Vanguard and Vagabond (hereinafter MIR M) is officially launching globally on January 31.


MIR M, a sequel to The Legend of Mir 2, received a lot of love from global players. It applied a modern twist to the traditional Mir IP, and added blockchain technology to the Korean version of MIR M, which already launched in June 2022.

MIR M maximized the original gameplay with 8-grid and quarter-view grid battle styles. The Mandala system allows players to choose between the path of a hero or an adventurer, giving players the freedom to choose their path and creating a unique experience exclusive to MIR M.

MIR M will introduce the governance token DOGMA and game token DRONE. WEMIX PLAY, the number 1 P&E (Play and Earn) gaming platform, will support the inter-game economy of MIR M and MIR4.

DOGMA, the core token that constitutes inter-game economy, can be obtained by staking DRONE from MIR M and HYDRA from MIR4.

Pre-registration is currently available on the official website. Players who pre-register can obtain special items and complete missions through an airdrop event to receive game token DOGMA.

MIR M will be serviced in more than 170 countries and support 12 languages. Mobile (Android, iOS) and PC versions will be released simultaneously.

For more information about MIR M: Vanguard and Vagabond, visit the official website.

Contacts

Wemade Co., Ltd. (112040: KOSDAQ)

Yeonghyun Lee, PR Manager

yeonghyun@wemade.com

Alex

Recent Posts

HighField Biopharmaceuticals ASCO 2024 Poster Presentation Shows HFK1, a Unique Immunoliposome May Improve Clinical Outcomes over Antibody Drug Conjugates

HFK1 is the company’s groundbreaking drug encapsulated immunoliposome for solid tumors with HER2 low expression…

25 mins ago

Bio-Sourcing and Partners Launch €3.4M EU Project in Inflammatory Indications with €1.9M EUREKA Eurostars Subsidies

AB-BIOBETTER to pioneer development of new oral formulation of adalimumab for inflammatory bowel diseases; offering…

26 mins ago

FOLLOWME TRADING CONTEST · MID-YEAR EVENT HONG KONG 2024 Concluded Spectacularly

HONG KONG SAR - Media OutReach Newswire - 28 May 2024 - On May 18th,…

42 mins ago

OPPO Teams Up with Global Brand Ambassador Kaká for Epic 2024 UEFA Champions League Final Celebrations

LONDON, UNITED KINGDOM - Media OutReach Newswire - 28 May 2024 - To celebrate this…

57 mins ago

The World’s First Pair of Nikkei 225 Leveraged & Inverse Products (L&Is) Outside of Japan to List on HKEX Tomorrow

HONG KONG--(BUSINESS WIRE)--Coupling with the first Nikkei 225 Index ETF (3153.HK) in Hong Kong, CSOP…

1 hour ago